Menopause Treatment Market Expected to Reach USD 1,308.0 Million by 2034, Growing at 5.6% CAGR

Menopause Treatment Market
Menopause Treatment Market

In the latest market analysis, the global menopause treatment market is projected to be valued at USD 758.5 million in 2024. As evolving trends and increased awareness drive demand, the market is anticipated to reach USD 1,308.0 million by 2034, reflecting a steady compound annual growth rate (CAGR) of 5.6% from 2024 to 2034.

The anticipated market expansion is fueled by the increasing recognition of the importance of managing menopause symptoms and the growing availability of innovative treatment options. As awareness and acceptance of menopause-related health issues rise, more women are seeking effective solutions, driving sales of menopause treatment products.

The significant growth of the global menopause treatment market is being driven by a better awareness of menopause symptoms and a greater focus on individualized healthcare solutions. As women’s health becomes increasingly customized, there is a noticeable trend toward customized therapy strategies to address the unique challenges and symptoms associated with menopause.

In addition, more and more people are becoming aware of the menopause and the wide range of symptoms it can cause. In the end, this benefits the market because it enables women to receive the treatment and remedies they require to manage these problems. The market for menopausal therapy substitutes is predicted to grow as more women become aware of the condition.

Key Takeaways:

  • The global menopause treatment market is expected to reach US$1.31 billion by 2034, growing at a CAGR of 5.6% from its 2024 valuation of US$758.5 million.
  • Rising demand for personalized treatment options is a key growth driver, as women seek solutions tailored to their unique menopausal experiences.
  • Increased awareness of menopause and its symptoms is prompting more women to seek treatment, propelling market growth.

Competitive Analysis:

Several menopause treatment providers dominate the competitive landscape, propelling developments and determining the market shift. Renowned pharmaceutical companies such as Eli Lilly and Company, Merck KGaA, Novartis AG, Bayers AG, and Pfizer, Inc. are at the vanguard. These menopause treatment providers’ comprehensive expertise and resources make them essential for market growth.

The prominent menopause treatment vendors comprise Novo Nordisk, Ascend Therapeutics, Mylan N.V. [Viatris], Cipla, Inc., and Glenmark Pharmaceuticals Ltd., each bringing their diverse strengths and product portfolio. Emerging menopause treatment creators like MenoGeniX, Perrigo Pharma International D.A.C., Ausio Pharmaceuticals, LLC, EndoCeutics, Inc., and Radius Health, Inc. bring innovation and modernization to the competitive landscape.

Top Menopause Treatment Providers:

  • Eli Lilly and Company
  • Merck KGaA
  • Novartis AG
  • Bayers AG
  • Pfizer, Inc.
  • Novo Nordisk
  • Ascend Therapeutics
  • Mylan N.V. [Viatris]
  • Cipla, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • MenoGeniX
  • Perrigo Pharma International D.A.C.
  • Ausio Pharmaceuticals, LLC
  • EndoCeutics, Inc.
  • Radius Health, Inc.

Key Segments

By Product:

  • Hormone Therapy
    • Combination
    • Tibolone
    • Progestin-only Medicines
    • Estrogen-only Medicines
  • Non-Hormonal Therapy
    • Gabapentinoids
    • Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
    • Selective Serotonin Reuptake Inhibitors (SSRI)
    • Others

By Route of Administration:

  • Topical
  • Injectable
  • Oral

By Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Supermarkets/ Hypermarkets
  • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

A Old Full Report Analysis Click Here

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Intraoral Scanner Market Set to Reach USD 1,548.0 Million by 2034, Growing at 7.6% CAGR

Global Intraoral Scanner Market
Global Intraoral Scanner Market

The global intraoral scanner market is projected to achieve a valuation of USD 744.7 million in 2024 and is expected to surpass USD 1,548.0 million by 2034. This significant growth represents a compound annual growth rate (CAGR) of 7.6% over the forecast period.

The rise in market valuation reflects the increasing adoption of advanced dental technology, particularly intraoral scanners, which offer enhanced accuracy, efficiency, and patient comfort in dental practices. These devices are becoming a crucial tool for modern dentistry, facilitating more precise digital impressions, improving diagnostic capabilities, and streamlining workflows.

As the demand for state-of-the-art dental solutions continues to grow, driven by both patient expectations and technological innovations, the intraoral scanner market is expected to experience robust expansion. This growth trajectory underscores the pivotal role of intraoral scanners in shaping the future of dental care.

With age, the risk of developing diseases rises correspondingly. The growing older population will spur interest in more advanced medical care facilities, and diagnostic and therapeutic options. The prevalence of age-related disorders is predicted to rise with the rapid global growth in the elderly population.

The market for intraoral scanners is also being driven by an increase in dental diseases and oral cancer. Regional governments are supporting several research projects that give the healthcare system access to cutting-edge technology, which will advance the industry, and support market growth.

Such governmental aid could encourage the development of novel products and boost the demand within the market throughout the predicted period.
Such advancements are fuelling the demand for 3D imaging of intraoral structures.

Nearly 47.2% of Americans over 30 in the United States have periodontal disease, according to the Centers for Disease Control and Prevention (CDC). Additionally, the growing use of dental prostheses has encouraged the development of innovative dental technology, and the established global healthcare infrastructure is actively encouraging market growth.

Due to the expansion of the market’s supply of licenses and permits, which has broadened the selection of products, intraoral scanners are now more widely available.

Additionally, the need for more advanced diagnostic and therapeutic equipment and facilities will rise as the population ages. It is anticipated that the prevalence of age-related ailments will rise as the global aged population grows significantly.

To promote the sector and provide products that adhere to regulations, businesses in the market are focusing on obtaining regulatory licenses. Because of the increased use of these devices, the market for intraoral scanners will develop.

Key Takeaways from Intraoral Scanners Market Study

  • The open system segment dominates the intraoral scanners market with over 97.2% value in 2021 due to its rising demand and ease of access.
  • Intraoral scanners dominate the intraoral scanners market with over 45.2% value share in 2021 as these scanners produce realistic yet accurate images of the teeth and their surrounding structures by capturing digital expressions directly.
  • The dental clinics segment dominates the intraoral scanners market with nearly 36.7% value share in 2021, owing to the increasing chronic oral diseases and with the rise of awareness of oral conditions.
  • North America accounts for the highest share of around 31.4% of the global intraoral scanners market in 2021, due to the increased incidence of oral cancer cases, increasing elderly population, and increase in the number of product approvals in this region.

“Over the projection period, the intraoral scanners market will experience growth due to rising oral cancer incidence and increased awareness of oral hygiene.” says an analyst of Future Market Insights.

Intraoral Scanners Market Competition

Leading industry players in the intraoral scanners market are focusing on the design, introduction, and approval of innovative products as a way to expand their product offerings and expand their geographic presence.

  • On 22nd October 2022, Align Technology launched the latest iTero-Exocade connector software
  • Straight Smile LLC (“Byte”), a market leader in the direct-to-consumer, doctor-directed clear aligner sector, was acquired by Dentsply Sirona on January 12, 2021.

Intraoral Scanners Market Key Players

  • Dentsply Sirona
  • 3Shape
  • Straumann
  • Align Technology
  • Amann Girrbach
  • 3D Totem
  • Shining 3D
  • Others

A Old Full Report Analysis Click Here

Key Segments Covered in Intraoral Scanners Market Research

By Product:

  • Intraoral Scanners
    • Benchtop Intraoral Scanners
    • Stand-alone CAD/CAM Scanners
    • 3D Handheld Scanners
  • Intraoral Cameras
  • Intraoral Sensors
  • Stand-Alone Software

By Modality:

  • Closed system
  • Open system

By End User:

  • Hospitals
  • Dental Clinics
  • Group Dental Practices
  • Ambulatory Surgical Centres

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Stethoscope Hygiene Devices Market Set to Reach USD 91.4 Million by 2032 at a 6.9% of CAGR

Global Stethoscope Hygiene Devices Market
Global Stethoscope Hygiene Devices Market

The global stethoscope hygiene devices market is projected to achieve a valuation of USD 47.4 million by the end of 2022, with anticipated growth at a compound annual growth rate (CAGR) of 6.9% over the next decade. By 2032, the market is expected to reach approximately USD 91.4 million.

The surge in demand for stethoscope hygiene devices is primarily attributed to the increasing emphasis on infection control within healthcare settings. With heightened awareness of the risks associated with cross-contamination, healthcare providers are increasingly adopting stethoscope hygiene devices to ensure patient safety.

In 2021, desktop stethoscope hygiene devices emerged as the dominant product category, capturing approximately 86.6% of the market share. This trend reflects the growing preference for reliable and efficient hygiene solutions that can be easily integrated into everyday medical practice.

The surge in the market is attributed to the escalating demand for stethoscope hygiene equipment, primarily fueled by the increasing healthcare needs of the ageing population. As the elderly seek primary diagnosis for a spectrum of chronic diseases, the demand for sophisticated stethoscopes has witnessed a significant upswing.

According to the Centres for Disease Control and Prevention, people over the age of 65 are more likely to acquire serious health problems such as heart disease, the flu, chronic obstructive pulmonary disease, asthma, and other ailments.

According to the World Ageing 2019 report, there were around 703 million adults aged 65 years or older worldwide in 2019, with this figure anticipated to quadruple to 1.5 billion by 2050. This demographic transition is anticipated to increase stethoscope usage, which may raise the requirement for good stethoscope hygiene maintenance. This increase in demand may benefit the market for Stethoscope Hygiene Devices.

However, the market is now hampered by a lack of knowledge and experience in stethoscope disinfection. Increasing knowledge of good stethoscope hygiene could be a crucial area for development, as it can help maintain hygiene standards.

As the use of stethoscopes grows, so will the need for and production of Stethoscope Hygiene Devices, creating a profitable growth opportunity for the market.

Key Takeaways from Stethoscope Hygiene Devices Market Study

  • Desk-top Stethoscope Hygiene Devices is the leading product segment, accounting for approximately 6% of the market value in 2021, owing to their broad availability and the restricted availability of wearable Stethoscope Hygiene Devices.
  • Because UV is widely used for disinfection of all different kinds of things like surface disinfection, etc., as these rays are known for killing the microorganisms present on the contaminated object, the UV segment is set to lead in terms of technology of Stethoscope Hygiene Devices, with a market value share of around 3% in 2021.
  • Hospitals will have the highest market share value of 6% in 2021. Because of the market’s number and diversity of healthcare experts, this segment has emerged as a market leader.
  • South Asia is considered the one most lucrative region with growth at a CAGR of 6% at the end of the forecast period, owing to the presence of market-specific products from India that have been launched recently.

“Rising demand for stethoscope use due to increasing geriatric population, and rising rates of nosocomial infection proliferation, are set to propel the sales of Stethoscope Hygiene Devices across the globe,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Stethoscope Hygiene Devices Market Competition

There are only a few new and existing players operating in the Global Stethoscope Hygiene Devices Industry, which is highly concentrated. To capture that market, businesses are launching new products in various geographical locations.

  • In 2020, Vioguard launched the Cubby Plus UV-C disinfecting chamber with applications at home as well as in healthcare facilities.
  • On February 15, 2021, the Indian business Xech introduced the first stethoscope steriliser in the country, the Xech Sterostet, which sterilises stethoscope diaphragms of all sizes using specialised UV-C GI technology.

Stethoscope Hygiene Devices Market Key Companies Profiled

  • LightProgress/egoHealth
  • Xech
  • Your First Services Inc.
  • Vioguard
  • Edmund Optics
  • Parsons
  • UV Smart
  • Tangshan UMG Medical Instrument Co., Ltd.

A Old Full Report Analysis Click Here

Key Segments Covered in Stethoscope Hygiene Devices Market Research

By Product:

  • Wearable
  • Desk-Top

By Usage:

  • UV
  • Glass Plasma

By End User:

  • Hospitals
  • Clinics
  • Academic & Research Institutions
  • Ambulatory Care Centres
  • Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Freeze Drying Market Forecasted to Reach USD 2,881.55 Million by 2034, Expanding at 8.6% CAGR

Freeze Drying Market
Freeze Drying Market

The global freeze drying market is set for robust growth, with a projected compound annual growth rate (CAGR) of 8.6% from 2024 to 2034. The market is expected to achieve a valuation of USD 1,262.78 million in 2024, and is forecasted to reach approximately USD 2,881.55 million by 2034.

This rapid expansion is being driven by significant growth in the food processing and pharmaceutical industries, two sectors where freeze drying plays a critical role. As these industries continue to evolve, the demand for freeze drying technology is expected to increase, fueled by the rising awareness of its advantages over traditional drying methods.

Freeze drying, known for its superior desiccant drying and air-drying efficiency, is becoming increasingly popular as a method for preserving the quality and extending the shelf life of various products. This is particularly true in the food and pharmaceutical industries, where maintaining the integrity of sensitive ingredients is paramount.

As a trailblazer in preserving product quality and extending shelf life, freeze drying is fast becoming an essential process in the food, pharmaceutical, and biotechnology industries. Its ability to eliminate water content from products without compromising their structural integrity or nutritional value is what drives its widespread acceptance and use.

The market for freeze drying is expected to grow in tandem with technological advancements and the increasing emphasis on product lifespan and quality. It is expected that leading firms in the market would leverage these advancements to drive innovation and enhance their offerings to meet the evolving needs of customers and industries.

Key Takeaways:

  • The global freeze drying market is estimated at US$1.26 billion in 2024 and is projected to reach US$2.88 billion by 2034, growing at a robust CAGR of 8.6%.
  • The expanding food processing and pharmaceutical industries are key drivers of market growth.
  • Rising awareness of freeze drying’s advantages, such as superior drying efficiency and product preservation, is fueling demand.

Competitive Analysis

The market for food freeze-drying machines has a competitive landscape with multiple freeze-drying manufacturers driving innovation and technological advancement. Leading providers of freeze drying exhibit creativity and innovation in a variety of technologies. Azbil Corporation, Zirbus Technology GmbH, and HOF Sonderanlagenbau GmbH all exhibit dependability and creative problem-solving.

The unique advantages of Cryotec.Fr, MechaTech Systems Ltd., and Millrock Technology, Inc. improve the competitive environment and drive the development of freeze-drying technology. Cuddon Freeze Dry, Martin Christ Gefriertrocknungsanlagen GmbH, and SP Industries, Inc. have a significant impact on the freeze drying market dynamics with their state-of-the-art lyophilized goods.

Pivotal Freeze Drying Providers:

  • Azbil Corporation
  • Zirbus Technology GmbH
  • HOF Sonderanlagenbau GmbH
  • Millrock Technology, Inc.
  • Cryotec.Fr
  • MechaTech Systems Ltd.
  • SP Industries, Inc.
  • Martin Christ Gefriertrocknungsanlagen GmbH
  • Cuddon Freeze Dry
  • Neologic Engineers Private Limited
  • Labconco Corporation
  • BÜCHI Labortechnik AG
  • Yamato Scientific America Inc.
  • Freeze Drying Systems Ltd.
  • Freeze Drying Systems Pvt. Ltd.
  • IMA – Industria Macchine Automatiche S.p.A.
  • GEA Group

A Old Full Report Analysis Click Here

Key Segments

By Product:

  • Dryer
    • Tray-style dryers
    • Rotary Freeze Dryers
    • Manifold Freeze Dryers
  • Accessories
    • Drying Chamber
    • Vacuum System
    • CIP (Clean-in-place) Systems
    • Other Accessories

By Scale of Operations:

  • Pilot-scale
  • Laboratory-scale
  • Industrial-scale

By Distribution Channel:

  • Biopharmaceutical Companies
  • Food and Beverage Companies
  • Academic and Research Institutes
  • CRO and CMO
  • Hospitals
  • Research Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Monoclonal Antibodies Market Expected to Reach USD 647.01 Billion by 2032 at a 12% of CAGR

Monoclonal Antibodies Market
Monoclonal Antibodies Market

The global monoclonal antibodies (mAbs) market, valued at USD 186 billion in 2021, is projected to grow at a robust compound annual growth rate (CAGR) of 12% from 2022 to 2032. This growth is driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular conditions, which are boosting the demand for biologics.

The expanding market is largely driven by the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and other serious health issues. As these diseases continue to affect a growing number of individuals globally, the demand for biologics, particularly monoclonal antibodies, is surging. These biologics have become a cornerstone in the treatment of various chronic conditions, offering targeted therapies that improve patient outcomes.

Moreover, the increasing application of mAb therapies in targeted treatments is gaining traction among healthcare professionals and patients alike. The growing awareness of the effectiveness and benefits of these therapies is expected to further fuel market growth.

Human mAbs offer efficient modulation in effector functions and are less immunogenic as compared to chimeric or humanized mAbs. Such antibodies can be produced through the use of phage display and hybridoma technologies in transgenic mice. As a result, with recent technological progress in genetic engineering, the production of fully human mAbs is anticipated to gain traction shortly.

North America recorded the largest market share of 46.2% in 2021 due to the presence of a highly developed healthcare infrastructure, high patient awareness, and growth in cancer research prospects, among other factors. Moreover, increasing government expenditure for cancer research and the presence of key players such as Pfizer Inc., Amgen, Inc., and Merck & Co., among others, are expected to boost the market growth. Rising healthcare expenditure across the world, increasing patient awareness levels, and availability of advanced hospital infrastructure in developed countries are factors expected to result in the dominance of the segment during the forecast period.

Key Takeaways from the Monoclonal Antibodies Market Study 

  • In 2022, the global monoclonal antibodies market size was valued at USD 186 billion in 2021.
  • The market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032
  • The human source type held the largest share and accounted for 54.07% of the market value in 2021.
  • The North American market for monoclonal antibodies expanded with a market share of 46.2% in 2022.
  • Asia Pacific is projected to exhibit the fastest growth rate in the forecast period.

“Applications of mAbs for the treatment of autoimmune diseases are projected to grow at a lucrative rate due to the increasing prevalence of autoimmune conditions such as rheumatoid arthritis.” comments a Future Market Insights analyst.

Monoclonal Antibodies Market Competitive Landscape 

The market is expected to become more competitive shortly, as many companies focus their efforts on research and the creation of innovative diagnostic techniques through product line expansions, acquisitions, and mergers.

Key players in the Monoclonal Antibodies Market are:

Novartis AG; Pfizer Inc; GlaxoSmithKline plc; Amgen Inc.; Merck & Co., Inc.; Daiichi Sankyo Company, Limited; Abbott Laboratories; AstraZeneca plc; Eli Lilly And Company; Johnson & Johnson Services, Inc. and many more.

  • In November 2021, Bristol-Myers Squibb Company received the U.S. Food and Drug Administration approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) combined with limited chemotherapy as first-line treatment of metastatic or recurrent non-small cell lung cancer. Patients with squamous or non-squamous illness, independent of PD-L1 expression, are eligible for the treatment. 1 The FDA’s Real-Time Oncology Examine (RTOR) pilot programme was used to review this application, which aims to ensure that safe and effective medicines are offered to patients as soon as feasible.
  • In March 2022, Sanofi S.A. and Blackstone Life Sciences entered a collaboration for accelerating the development of a subcutaneous formulation of Sarclisa mAb for the treatment of patients with multiple myeloma.

More Valuable Insights 

Future Market Insights, in its new offering, presents an unbiased analysis of the global monoclonal antibodies market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights based on test type (tumor biomarkers tests, imaging, biopsy, liquid biopsy, immunohistochemistry, in situ hybridization), by indication (breast cancer, lung cancer, colorectal cancer, melanoma, blood cancer, prostate cancer, ovarian cancer, stomach cancer, liver cancer and others) and by end-user (hospital-associated labs, independent, diagnostic laboratories, diagnostic imaging centers, cancer research institutes and others) and regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

A Old Full Report Analysis Click Here

Key Segments Profiled in the Monoclonal Antibodies Market Industry Survey

Monoclonal Antibodies Market by Production Type:

  • In Vivo
  • In Vitro

Monoclonal Antibodies Market by Source Type:

  • Murine
  • Chimeric
  • Humanized
  • Human

Monoclonal Antibodies Market by End User:

  • Hospitals
  • Specialty Centers
  • Others

Monoclonal Antibodies Market by Application:

  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Neurological Diseases
  • Others

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Drug Formulation Market Set to Reach USD 1.58 Trillion by 2022, With Oral Formulations Leading Growth at 6.0% CAGR

Drug Formulation Market
Drug Formulation Market

The global drug formulation market is anticipated to grow significantly, with a projected compound annual growth rate (CAGR) of 5.6% from 2022 to 2032. The market for drug formulations is estimated to achieve a valuation of USD 1.58 trillion by the end of 2022, reflecting robust growth and increased market activity.

Oral formulations are expected to be a major driver of this growth, projected to expand at an impressive CAGR of 6.0% during the forecast period. This segment’s growth is attributed to the increasing preference for oral drug delivery systems due to their convenience and ease of administration.

As the demand for efficient and effective drug formulations continues to rise globally, the market is on a strong trajectory for significant expansion over the next decade.

Because it makes it easier to convert active pharmaceutical ingredients (APIs) into completed medications that are safe for people to take, the global drug formulation market is essential to the pharmaceutical sector. Both the rising demand for pharmaceutical products and improvements in the technology of medicine formulation account for the anticipated growth.

Key Takeaways:

  • The global drug formulation market is expected to reach USD 2.87 trillion by 2032, growing at a CAGR of 5.6%.
  • Oral formulations are projected to experience the fastest growth, with a CAGR of 6.0% during the forecast period.
  • Rising demand for innovative drug delivery systems and growing healthcare needs worldwide are key drivers.

Competitive Landscape:

In the medication formulation industry, major players are employing methods such as advanced product launches through approvals and mergers and acquisitions. The major businesses are concentrating on working with the research institutes to gain a competitive edge in the marketplace.

  • A definitive merger agreement between Bristol Myers Squibb and Turning Point Therapeutics was signed on June 20, 2022. This acquisition will expand BMS’s selection of oncology drugs because Turning Point Therapeutics is a precision oncology company that is still in the clinical development stage.
  • AstraZeneca introduced The Evusheld long-acting antibody combo to the public on March 20, 2022. For the pre-exposure prophylaxis (prevention) of COVID-19 in a sizable population, it has received authorization in Europe.

Key Companies Profiled:

  • AstraZeneca plc.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • 3M Company
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • Sanofi SA
  • GlaxoSmithKline plc
  • Boston Scientific Corporation
  • Gerresheimer AG
  • Nimbus Therapeutics
  • Antares Pharma, Inc.
  • IDEAYA Biosciences, Inc.

A Old Full Report Analysis Click Here

Key Market Segments Covered in Drug Formulation Industry Research:

By Dosage Form:

  • Oral formulations
    • Tablets
      • Immediate Release
      • Modified Release
      • Chewable
      • Effervescent
    • Capsules
      • Hard Gelatin Capsules
      • Softgel Capsules
      • Others
    • Powders & Granules
    • Lozenges & Pastilles
    • Gummies
    • Others
  • Parenteral formulations
    • Solutions
    • Suspensions
    • Emulsions for injection or infusion
    • Powders for injection or infusion
    • Gels for injection implants
  • Topical formulations
    • Pastes
    • Ointments and oils
    • Creams, lotions, and foams.
    • Gels, tinctures, and powders
    • Sprays and patches
  • Inhalation formulations
    • Pressurized Metered Dose Inhaler
    • Dry Powder Inhaler (DPI)
    • Nebulizer

By Indication:

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Gastrointestinal Diseases
  • Musculoskeletal Disorders
  • Dermatological Disorders
  • Other

By End User:

  • Big pharma
  • Small & Medium Size Pharma
  • Biotech Companies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Synthetic Biology Market to Soar to USD 31.73 Billion by 2034 at a 23.8% of CAGR

Synthetic Biology Market
Synthetic Biology Market

The global synthetic biology market is set for extraordinary expansion, with a projected rise from USD 3.75 billion in 2024 to an impressive USD 31.73 billion by 2034. This growth represents a remarkable compound annual growth rate (CAGR) of 23.8% over the forecast period.

This rapid growth is driven by the increasing need to enhance practical capabilities, redesign naturally occurring systems, and develop new biological components, tools, and systems. Synthetic biology is becoming an essential driver of innovation in industries that rely on bio-based chemicals, renewable fuels, and cost-effective medications and vaccines.

In addition, the global push for genetically modified crops to meet the food demands of an ever-expanding population is contributing significantly to the market’s momentum. As advancements in synthetic biology continue to revolutionize multiple sectors, the market is well-positioned for sustained growth over the next decade.

At the same time, utmost care needs to be taken to see that government protocols are followed for selling any of the synthetic biology products in the market.

Genetically engineered products, gene synthesis, DNA sequencing, NGS (next-generation sequencing), and bioinformatics are enhancing research in this field of medicine at the global level.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Synthetic Biology Market’. It has its line of expertise in the form of analysts and consultants to execute using a 360-degree approach in its primary, secondary, and tertiary modes of research.

“With discovery of novel therapeutic targets to treat diseases like cancer on the anvil, the global synthetic biology market is slated to grow voraciously in the upcoming period”, says an analyst from Future Market Insights.

Bioengineering is an interdisciplinary field of science that combines biology and engineering principles to design and build new biological systems or modify existing ones. It involves the application of engineering principles to biological systems, with the goal of creating new and useful functions that are not found in nature.

Key Takeaways from Synthetic Biology Market

  • North America holds the largest market share with the US being home to maximum biopharmaceutical and pharmaceutical companies.
  • Europe holds a significant market share on the back of Germany. This is evident from the fact that Robert Koch Institute, in the year 2019, had 502,655 people based out of Germany diagnosed with cancer. This calls for high-level adoption of synthetic products amongst the Germans.
  • The Asia-Pacific is expected to be led by China. This could be credited to nigger strategic investment in research in synthetic biology, thereby boosting the bio-economy in the forecast period.

Competitive Biology

  • Novozymes, in January 2021, did launch Frontia GlutenEx with the objective of assisting wheat processors to increase recovery rate of gluten protein and also cut down on consumption of energy.
  • Merck, in February 2021, entered into partnership with BioNtech for supplying lipids for manufacturing Pfizer-BioNtech Covid-19 vaccine (BNT162b2).
  • Merck, in January 2021, completed acquisition of AmpTec to strengthen the product portfolio for manufacturing and developing mRNA to facilitate diagnostics, treatments, and vaccination.
  • Ribbon Biolabs, in January 2022, did raise a series A financing fund worth EUR 18 Million with the objective of enabling production facilities at the commercial scale along with DNA synthesis technology’s expansion in the US.
  • GenScript, in November 2021, did expand the gene synthesis production capacities in the US with 100% automated oligo synthesis along with sequencing platforms.
  • The PABC (Pennsylvania Biotechnology Center), in September 2022, did announce that Thermo Fisher Scientific joined hands as one of the founding sponsors of PABC campus at Doylestown; along with its novel B+Labs incubator in Philadelphia; wherein upcoming life science companies could catalyze the way to commercialization.
  • Medichem and Bota Bio, in August 2022, did commit to promote sustainability while improvising on industrial processes. The latter’s expertise with respect to enzyme engineering would be used for developing enzymes that could be effortlessly incorporated into former’s chemical processes.
  • Codexis, in July 2021, along with Kalsec, Inc., did announce expanding research collaboration for manufacturing Kalsec’s natural hop acid.

Key Market Players:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Novozymes
  • Agilent Technologies, Inc.
  • Codexis, Inc.
  • Bota Biosciences Inc.
  • Creative Biogene.
  • Creative Enzymes.
  • Enbiotix, Inc.
  • Illumina, Inc.
  • Other

Key Market Segments Covered in Synthetic Biology Industry Research

By Product:

  • Oligonucleotides
  • Enzymes
  • Synthetic Cells
  • Cloning Technologies Kits
  • Xeno-Nucleic Acids
  • Chassis Organism

By Application:

  • Healthcare
  • Non-Healthcare

By End User:

  • Biotechnology and Pharmaceutical companies
  • Academic and Government Research Institutes
  • Others

At the same time, utmost care needs to be taken to see that government protocols are followed for selling any of the synthetic biology products in the market.

Genetically engineered products, gene synthesis, DNA sequencing, NGS (next-generation sequencing), and bioinformatics are enhancing research in this field of medicine at the global level.

Future Market Insights has walked through these facts with future perspectives in its latest market study entitled ‘Synthetic Biology Market’. It has its line of expertise in the form of analysts and consultants to execute using a 360-degree approach in its primary, secondary, and tertiary modes of research.

“With discovery of novel therapeutic targets to treat diseases like cancer on the anvil, the global synthetic biology market is slated to grow voraciously in the upcoming period”, says an analyst from Future Market Insights.

Bioengineering is an interdisciplinary field of science that combines biology and engineering principles to design and build new biological systems or modify existing ones. It involves the application of engineering principles to biological systems, with the goal of creating new and useful functions that are not found in nature.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cardiac Ambulatory Monitoring Market to Expand to USD 21.8 Billion by 2031 at a 5.2% of CAGR

Global Cardiac Ambulatory Monitoring Market
Global Cardiac Ambulatory Monitoring Market

The global cardiac ambulatory monitoring market, valued at USD 13.3 billion in 2021, is set for substantial growth, with a projected compound annual growth rate (CAGR) of 5.2% over the forecast period. By 2031, the market is expected to reach approximately USD 21.8 billion, according to a recent study by Future Market Insights.

A key driver of this growth is the increasing adoption of ECG devices, which currently dominate the cardiac ambulatory monitoring market. In 2021, ECG devices accounted for approximately 42.2% of the market share, reflecting the rising demand for efficient cardiac monitoring solutions in outpatient settings.

This steady market expansion is attributed to advancements in technology, the growing prevalence of cardiovascular diseases, and a shift towards more accessible, patient-centric healthcare solutions. As the healthcare industry continues to innovate, the cardiac ambulatory monitoring market is poised for sustained growth in the years to come.

During the projected period, the global market is anticipated to be driven by the steadily rising use of cardiac ambulatory monitoring devices for the treatment of cardiac arrhythmia and other cardiac disorders. Cardiac ambulatory monitors can be used both inside and externally. For instance, implantable loop recorders with a three-year battery life can be placed transdermal. As a result, the electrical activity of the heart is continuously monitored.

Due to the rapid advancement of technology, rising rates of cardiovascular disorders around the world, and an aging population, the market for cardiac ambulatory monitoring is growing at a rapid rate. The market for cardiac ambulatory monitoring devices is anticipated to grow significantly over the next few years as a result of improvements in technology and innovations in cardiac ambulatory monitoring devices.

As cardiac ambulatory monitoring devices are not reaching the customer at their full potential due to associated side effects and the pricey nature of the devices, companies are introducing portable cardiac ambulatory monitoring devices at reasonable costs, and this might significantly improve the usability and adoption of cardiac ambulatory monitoring devices.

Manufacturers releasing products like portable/wearable gadgets with cutting-edge features like Bluetooth connectivity, integral ECG monitors, fitness trackers, and other numerous functions, will help in growing sales of the devices, as a result, the cardiac ambulatory monitoring market will expand during the forecast period.

Key Takeaways from Market Study

  • ECG devices are the leading segment as a product and hold approximately 42.2% market share in 2021. Owing to their lower pricing, these devices can also be utilized in medical operations, along with a variety of other cardiac diagnostic tests, telemetry monitoring equipment, and other tools.
  • Hospitals are the leading segment as end users, and held about 35.0% market share in 2021, due to the rising incidence of CVDs, the rising number of hospital visits, and the rising number of cardiac device implantation procedures.
  • By region, North America is leading the global cardiac ambulatory monitoring market and is expected to continue to do so with a projected CAGR of 4.4% during the forecasted years.
  • The region of Europe is slated to be the second dominant segment in terms of growth, holding a market share of around 25.6% in the global cardiac ambulatory monitoring market, in 2021.

“Rising initiatives to promote a healthy lifestyle, as well as the increasing awareness about the cardiac monitoring devices is set to propel the sales of cardiac ambulatory monitoring devices across the globe,” says an analyst of Future Market Insights.

Market Competition

Major manufacturers concentrate on a range of strategic goals, including regional growth, product development, and strategic alliances and partnerships. For quick and simple diagnosis, new portable monitoring devices are being introduced for heart activity monitoring.

  • Boston Scientific Corporation stated in January 2021 that it has acquired Preventice Solutions Inc. to provide ambulatory cardiac monitors (including short- and long-term Holter monitors), cardiac event monitors, and MCT.
  • In order to increase the production of AEDs for cardiac monitoring and provide related services and accessories, ZOLL Medical Corporation announced in August 2019 that it has acquired Cardiac Science Corporation.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Teeth Whitening Market Projected to Reach USD 10,766.7 Million by 2034 at a 4.10% of CAGR

Teeth Whitening Market
Teeth Whitening Market

The global teeth whitening market is on track to reach an estimated valuation of USD 7,204 million by 2024. With an expected compound annual growth rate (CAGR) of 4.10% through 2034, the market is anticipated to surpass USD 10,766.7 million by the end of the forecast period.

Companies in the sector are responding to diverse consumer needs by offering personalizable solutions tailored to individual preferences, including products aimed at different age groups. This focus on customization is expected to fuel market expansion and position the industry for sustained growth.

As teeth whitening products continue to gain popularity worldwide, businesses are seeking innovative ways to cater to a broad range of customers, ensuring the market remains vibrant and competitive in the years ahead.

About 47.2% of Americans over 30 in the U.S. have periodontal disease, according to the CDC. Additionally, increasing number of dental aesthetic operations has led to the development of new technology in cosmetic dentistry, and the established healthcare infrastructure is substantially supporting market expansion on a global level.

Due to this there are now more licences and permits available on the market for teeth whitening products, which has increased the variety of products available. Enterprises in the market are focusing on obtaining regulatory approvals in order to advance the sector and offer items that adhere to rules.

Thus, the market for teeth whitening will expand due to the growing usage of these products.

Key Takeaways from Market Study

  • The teeth whitening devices segment accounted for around 0% share of total teeth whitening market in 2021, owing to a rise in the awareness for oral hygiene as well as education of people regarding treatment of periodontal diseases through these devices.
  • The retail sales segment dominates the teeth whitening market with about 0% share in 2021, owed to the increasing need for teeth whitening products.
  • North America accounts for the highest share of 4% of the global teeth whitening market share in 2021, due to the increased incidence of oral cancer cases, increasing influence of social media, and increase in the number of product approvals in this region.
  • Europe is slated to be the second largest region for teeth whitening market, holding a market share of around 2% in the global market, in 2021, owed to the presence of a high number of independent dental practices.

“Increasing incidence of periodontitis and associated diseases, and increasing number of approvals by the regulatory bodies for teeth, are factors set to boost the market over the forecast period,” says an analyst of Future Market Insights.

Market Competition

In order to diversify their product offerings and increase their geographical presence, leading industry participants in the teeth whitening market are concentrating on the development, introduction, and approval of innovative products.

  • American Orthodontics and Ultradent Goods, Inc. established a partnership on February 8, 2021, in which American Orthodontics would exclusively distribute Ultradent’s Opal Orthodontics branded products to orthodontists in the United States.
  • Repair and Protect with Deep Repair toothpaste was introduced by GSK Consumer Healthcare in September 2021 to provide a minty and whitening toothpaste for people who have dentine hypersensitivity.

Key Companies Profiled

  • Procter & Gamble
  • Colgate Palmolive
  • Johnson & Johnson
  • Unilever
  • Ultradent Products Inc.
  • Church & Dwight Co.
  • GlaxoSmithKline Plc
  • 3M Company
  • DENTSPLY international
  • Henkel AG & Co KGaA
  • Others

Teeth Whitening Market by Category

By Product:

  • Teeth Whitening Gels & Strips
    • Carbamide Peroxide with Potassium Nitrate and Fluoride
    • Carbamide Peroxide
    • Hydrogen Peroxide
  • Teeth Whitening Devices
    • LED Lights
      • Corded LED Lights
      • Cordless LED Lights
    • UV Lights
    • Halogen Lights
  • Oral Care Products
  • Others

By Distribution Channel:

  • Institutional Sales
    • Dental Hospitals
    • Dental Clinics
    • Group Dental Practice
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Hypermarket and Supermarket
    • Online Sales

About 47.2% of Americans over 30 in the U.S. have periodontal disease, according to the CDC. Additionally, increasing number of dental aesthetic operations has led to the development of new technology in cosmetic dentistry, and the established healthcare infrastructure is substantially supporting market expansion on a global level.

Due to this there are now more licences and permits available on the market for teeth whitening products, which has increased the variety of products available. Enterprises in the market are focusing on obtaining regulatory approvals in order to advance the sector and offer items that adhere to rules.

Thus, the market for teeth whitening will expand due to the growing usage of these products.

Key Takeaways from Market Study

  • The teeth whitening devices segment accounted for around 0% share of total teeth whitening market in 2021, owing to a rise in the awareness for oral hygiene as well as education of people regarding treatment of periodontal diseases through these devices.
  • The retail sales segment dominates the teeth whitening market with about 0% share in 2021, owed to the increasing need for teeth whitening products.
  • North America accounts for the highest share of 4% of the global teeth whitening market share in 2021, due to the increased incidence of oral cancer cases, increasing influence of social media, and increase in the number of product approvals in this region.
  • Europe is slated to be the second largest region for teeth whitening market, holding a market share of around 2% in the global market, in 2021, owed to the presence of a high number of independent dental practices.

“Increasing incidence of periodontitis and associated diseases, and increasing number of approvals by the regulatory bodies for teeth, are factors set to boost the market over the forecast period,” says an analyst of Future Market Insights.

Market Competition

In order to diversify their product offerings and increase their geographical presence, leading industry participants in the teeth whitening market are concentrating on the development, introduction, and approval of innovative products.

  • American Orthodontics and Ultradent Goods, Inc. established a partnership on February 8, 2021, in which American Orthodontics would exclusively distribute Ultradent’s Opal Orthodontics branded products to orthodontists in the United States.
  • Repair and Protect with Deep Repair toothpaste was introduced by GSK Consumer Healthcare in September 2021 to provide a minty and whitening toothpaste for people who have dentine hypersensitivity.

Key Companies Profiled

  • Procter & Gamble
  • Colgate Palmolive
  • Johnson & Johnson
  • Unilever
  • Ultradent Products Inc.
  • Church & Dwight Co.
  • GlaxoSmithKline Plc
  • 3M Company
  • DENTSPLY international
  • Henkel AG & Co KGaA
  • Others

A Old Full Report Analysis Click Here

Teeth Whitening Market by Category

By Product:

  • Teeth Whitening Gels & Strips
    • Carbamide Peroxide with Potassium Nitrate and Fluoride
    • Carbamide Peroxide
    • Hydrogen Peroxide
  • Teeth Whitening Devices
    • LED Lights
      • Corded LED Lights
      • Cordless LED Lights
    • UV Lights
    • Halogen Lights
  • Oral Care Products
  • Others

By Distribution Channel:

  • Institutional Sales
    • Dental Hospitals
    • Dental Clinics
    • Group Dental Practice
  • Retail Sales
    • Retail Pharmacies
    • Drug Stores
    • Hypermarket and Supermarket
    • Online Sales

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Peripheral Vascular Devices Market Set to Reach USD 8.9 Billion by 2032 at a 6.6% of CAGR

Global Peripheral Vascular Devices Market
Global Peripheral Vascular Devices Market

The global peripheral vascular devices market is projected to achieve a valuation of USD 4.7 billion by the end of 2022, with anticipated growth at a compound annual growth rate (CAGR) of 6.6%. By 2032, the market is expected to expand to USD 8.9 billion, according to the latest study by Future Market Insights.

Peripheral vascular stents are a major driver of this growth, leading the market with a substantial share of approximately 78.5% in 2021. These devices play a critical role in the treatment of peripheral artery disease (PAD) and other vascular conditions, contributing significantly to the market’s expansion.

Crucial information and forecast statistics covered in the Peripheral Vascular Devices market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

Peripheral Vascular Devices Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Peripheral Vascular Devices market. Competitive information detailed in the Peripheral Vascular Devices market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Peripheral Vascular Devices market report.

Key players covered in the report include:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • MicroPort Scientific Corporation
  • Medtronic Plc.
  • Cardinal Health, Inc.
  • Others

Important Questions Answered in the Peripheral Vascular Devices Market Report

  • Which end user remains the top revenue contributor in different regional markets?
  • At what rate has the global Peripheral Vascular Devices market been expanding during the forecast period?
  • How will the global Peripheral Vascular Devices market look like by the end of the forecast period?
  • What innovative strategies are adopted by Peripheral Vascular Devices market players to stay ahead of the pack?
  • What are the restraints affecting the growth of the global Peripheral Vascular Devices market?

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Peripheral Vascular Devices market

Peripheral Vascular Devices Market: Segmentation

Valuable information covered in the FMI’s Peripheral Vascular Devices market report has been segregated into key segments and sub-segments.

By Product:

  • Peripheral Vascular Stents
    • Self-Expanding Stents
    • Balloon Expanding Stents
    • Covered Stents
  • Drug Eluting Stents
  • Drug Eluting Balloons
  • Peripheral Vascular Bioresorbable Scaffolds

By Indication:

  • Target Artery Instability (TAI)
  • Access Artery Injury (AAI)
  • Peripheral Arterial Disease
  • Arteriovenous Fistulas
  • Peripheral Aneurysms
  • Others

By Artery:

  • Carotid Artery
  • Fem-Pop Artery
  • lliac Artery
  • Infrapop Artery

By End User:

  • Hospitals
  • Ambulatory Surgical Centers/Outpatients
  • Cardiac Catheterization Labs

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube